Diversity and intensity of adverse events in the treatment of hypertension with barnidipine

Blood Pressure

Volumn 7, Issue SUPPL. 1, 1998, Pages 27-29

  Van Der Velden, Jan Willem ^a   Beudeker, Han J ^a   Nishi, Motohide ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

adverse events; barnidipine; calcium antagonist; clinical trials

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; MEPIRODIPINE; DRUG DERIVATIVE; NIFEDIPINE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; EDEMA; FLUSHING; HEART PALPITATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; VASODILATATION; VERTIGO; ARTICLE; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

AGED; CALCIUM CHANNEL BLOCKERS; HUMANS; HYPERTENSION; NIFEDIPINE; TREATMENT OUTCOME;

EID: 80052114787     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/080370598438573     Document Type: Conference Paper

References (6)

1. Dougall HT, McLay JA. A comparative review of the adverse effects of calcium antagonists. Drug Safety 1996; 15(2): 91-106. (Pubitemid 26288229)
2. Satoh H. Pharmacology and therapeutic effects of mepirodipine. Cardiovasc Drug Rev 1991; 9(4): 340-56.
3. Stephens MDB. The detection of new adverse drug reactions. 2nd ed. London: Macmillan Press, 1988.
4. Lewis JG. Adverse reactions to calcium antagonists. Drugs 1983; 25: 196-222. (Pubitemid 13138068)
5. Psaty BH, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995; 274: 620-5.
6. Borchard U. Calcium antagonists in comparison: view of the pharmacologist. J Cardiovasc Pharmacol 1994; 24 (Suppl 2): S85-91. (Pubitemid 24369889)